Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Evaluating Translational AI: A Two-Way Moving Target Problem.

PMID: 41613162 ·

R, i, c, h, a, r, d, , K, , L, e, u, c, h, t, e, r, ;, , W, i, l, l, i, a, m, , B, , T, u, r, n, e, r, ;, , D, a, v, i, d, , O, u, y, a, n, g

RevistaNEJM AI
Año
PMID41613162

Resumen

Predictive artificial intelligence models are being deployed across health systems with dangerously inconsistent oversight, creating two critical gaps: a compliance gap, where clinical tools that likely qualify as software as a medical device are implemented without seeking U.S. Food and Drug Administration authorization; and a regulatory gap, where administrative and operational models are deployed without any external review despite their potential to influence care and widen disparities. Give

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑